Barely Significant
← all excerpts

Clinical and Electrophysiological Changes in Pediatric Spinal Muscular Atrophy after 2 Years of Nusinersen Treatment.

Pharmaceutics · 2022 · PMC9611420 · PMID 36297509

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
For SMA types 1 and 2, the age at the treatment initialization is highly significant ( p < 0.0001) and correlated with treatment yield.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.